Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?

Eur J Drug Metab Pharmacokinet. 2021 Nov;46(6):817-820. doi: 10.1007/s13318-021-00721-0. Epub 2021 Sep 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects*
  • Dihydropyrimidine Dehydrogenase Deficiency / chemically induced*
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Fluorouracil / adverse effects*
  • Gastrointestinal Tract / drug effects*
  • Humans
  • Kidney Diseases / chemically induced*

Substances

  • Antimetabolites, Antineoplastic
  • Fluorouracil